FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Alogliptin Tablets
Status: Currently in Shortage
»Date first posted: 08/14/2019
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Perrigo Company PLC (Revised 05/12/2020)

Company Contact Information:
269-673-8451

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
12.5mg, 30 Tablets (NDC 45802-0103-65) Available Demand increase for the drug
25mg, 30 Tablets (NDC 45802-0150-65) Available Demand increase for the drug
6.25mg, 30 Tablets (NDC 45802-0087-65) Available Demand increase for the drug

Takeda Pharmaceuticals USA Inc. (Revised 04/28/2020)

Company Contact Information:
877-825-3327

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
6.25 mg, 30 Tablets (NDC 64764-625-30) Available
12.5 mg, 30 Tablets (NDC 64764-125-30) Available
25 mg, 30 Tablets (NDC 64764-250-30) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English